Table 2 Comparison of demographic and clinical data of patients by PRD
From: Psychosocial and economic impact of rheumatic diseases on caregivers of Mexican children
Total 200 n (%) | JIA 109 n (%) | JDM 28 n (%) | JSLE 63 n (%) | P value* | ||
|---|---|---|---|---|---|---|
Age in years, median (IQR) | 13 (10–15) | 12 (9–15) | 11 (8.2–13.7) | 14.5 (12–16) | 0.01** | |
Female | 134 (67) | 66 (60.6) | 19 (67.9) | 49 (77.8) | 0.14 | |
JIA category | ERA | NA | 6 (5.5) | NA | NA | NA |
Oligoarticular | 8 (7.3) | |||||
Polyarticular | 66 (60.6) | |||||
Psoriatic | 1 (0.9) | |||||
Systemic | 16 (14.7) | |||||
Undifferentiated | 12 (11) | |||||
Cutaneous symptoms | 82/193 (42.5) | 15 (13.8) | 28 (100) | 39/56 (69.6) | < 0.001 | |
Musculoskeletal symptoms a | 161/193 (83.4) | 109 (100) | 27 (96.4) | 25/56 (44.6) | < 0.001 | |
Systemic symptoms b | 62/193 (32.1) | 11 (10.1) | 4 (14.3) | 47/56 (83.9) | < 0.001 | |
Treatment | NSAID | 80/179 (44.7) | 61/97 (62.9) | 5/27 (18.5) | 14/55 (25.5) | < 0.001 |
DMARD | 168/179 (93.9) | 90/97 (92.8) | 26/27 (96.3) | 52/55 (94.5) | 0.77 | |
GC | 82/179 (45.8) | 18/97 (18.6) | 25/27 (92.6) | 39/55 (70.9) | < 0.001 | |
bDMARD | 53/179 (29.6) | 49/97 (50.5) | 1/27 (3.7) | 3/55 (5.5) | < 0.001 | |
Hospitalization | 97/174 (55.7) | 29/93 (31.2) | 23/26 (88.5) | 45/55 (81.8) | < 0.001 | |
Disability | 43/174 (24.7) | 19/93 (20.4) | 16/26 (61.5) | 8/55 (14.5) | < 0.001 | |
Active Disease | 87/174 (50) | 34/93 (36.6) | 20/26 (76.9) | 33/55 (60) | < 0.001 | |